Chansamouth Vilada, Chommanam Danoy, Roberts Tamalee, Keomany Sommay, Paphasiri Viladeth, Phamisith Chanthala, Sengsavang Siho, Detleuxay Khamsay, Phoutsavath Phisith, Bouthavong Sengvong, Douangnouvong Anousone, Vongsouvath Manivanh, Rattana Sommana, Keohavong Bounxou, Day Nicholas P J, Turner Paul, van Doorn H Rogier, Mayxay Mayfong, Ashley Elizabeth A, Newton Paul N
Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU), Mahosot Hospital, Vientiane City, Lao PDR.
Microbiology Laboratory, Mahosot Hospital, Vientiane City, Lao PDR.
Lancet Reg Health West Pac. 2022 Jul 9;27:100531. doi: 10.1016/j.lanwpc.2022.100531. eCollection 2022 Oct.
Antimicrobial use (AMU) is a key driver of antimicrobial resistance (AMR). There are few data on AMU, to inform optimizing antibiotic stewardship, in the Lao PDR (Laos).
Point prevalence surveys (PPS) of AMU were conducted at four-month intervals in six general hospitals across Laos from 2017 to 2020, using modified Global-PPS data collection tools. The surveys focused on AMU amongst hospitalized inpatients.
The overall prevalence of inpatient AMU was 71% (4,377/6,188), varying by hospital and survey round from 50·4% (135/268) to 88·4% (61/69). Of 4,377 patients, 44% received >one antimicrobial. The total number of prescriptions assessed was 6,555. Ceftriaxone was the most commonly used (39·6%) antimicrobial, followed by metronidazole (17%) and gentamicin (10%). Pneumonia was the most common diagnosis among those prescribed antimicrobials in both children aged ≤5 years (29% among aged ≤1 year and 27% among aged >1 to ≤5years) and adults aged ≥15 years at 9%. The percentage of antimicrobial use compliant with local treatment guidelines was 26%; inappropriate use was mainly found for surgical prophylaxis (99%). Adult patients received ACCESS group antimicrobials less commonly than children (47% vs 63%, p-value<0·0001). Most WATCH group prescriptions (99%) were without a microbiological indication.
AMU among hospitalized patients in Laos is high with frequent inappropriate use of antimicrobials, especially as surgical prophylaxis. Continued monitoring and enhanced antimicrobial stewardship interventions are needed in Lao hospitals.
The Wellcome Trust [Grant numbers 220211/Z/20/Z and 214207/Z/18/Z] and bioMérieux.
抗菌药物的使用是抗菌药物耐药性(AMR)的关键驱动因素。在老挝人民民主共和国(老挝),关于抗菌药物使用情况的数据很少,无法为优化抗生素管理提供参考。
2017年至2020年期间,采用改良的全球现患率调查(Global-PPS)数据收集工具,每隔四个月在老挝的六家综合医院进行一次抗菌药物使用情况的现患率调查(PPS)。这些调查主要关注住院患者的抗菌药物使用情况。
住院患者抗菌药物使用的总体患病率为71%(4377/6188),因医院和调查轮次而异,从50.4%(135/268)到88.4%(61/69)不等。在4377名患者中,44%接受了一种以上的抗菌药物。评估的处方总数为6555份。头孢曲松是最常用的(39.6%)抗菌药物,其次是甲硝唑(17%)和庆大霉素(10%)。在≤5岁儿童(≤1岁儿童中为29%,>1至≤5岁儿童中为27%)和≥15岁成人中,肺炎是使用抗菌药物患者中最常见的诊断,在成人中占9%。符合当地治疗指南的抗菌药物使用百分比为26%;不当使用主要见于外科预防(99%)。成年患者使用ACCESS组抗菌药物的频率低于儿童(47%对63%,p值<0.0001)。大多数WATCH组处方(99%)没有微生物学指征。
老挝住院患者的抗菌药物使用情况较高,抗菌药物使用不当的情况频繁发生,尤其是在外科预防方面。老挝医院需要持续监测并加强抗菌药物管理干预措施。
惠康信托基金会[资助编号220211/Z/20/Z和214207/Z/18/Z]和生物梅里埃公司。